|
HS Code |
195520 |
| Name | 6-bromo-1H-pyrrolo[3,2-b]pyridine |
| Molecular Formula | C7H5BrN2 |
| Molecular Weight | 197.03 g/mol |
| Cas Number | 876708-60-2 |
| Appearance | Off-white to light brown solid |
| Melting Point | 146-150 °C |
| Smiles | Brc1ccc2nccc2n1 |
| Inchi | InChI=1S/C7H5BrN2/c8-5-2-4-10-6-1-3-9-7(5)6/h1-4H,(H,9,10) |
| Solubility | Soluble in DMSO, slightly soluble in water |
| Purity | Typically ≥98% (check specific supplier for confirmation) |
| Storage Temperature | Store at 2-8 °C |
| Synonyms | 6-Bromo-7-azaindole |
As an accredited 6-bromo-1H-pyrrolo[3,2-b]pyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle, 5 grams, labeled "6-bromo-1H-pyrrolo[3,2-b]pyridine," with hazard symbols, lot number, and safety instructions. |
| Container Loading (20′ FCL) | 20′ FCL container loaded with securely packed drums of 6-bromo-1H-pyrrolo[3,2-b]pyridine, ensuring safety and compliance during transit. |
| Shipping | 6-Bromo-1H-pyrrolo[3,2-b]pyridine is shipped in a tightly sealed container, protected from moisture and light. All packaging complies with regulations for hazardous substances, including appropriate labeling. During transit, the chemical is handled as a laboratory reagent and delivered via certified courier specializing in chemical materials to ensure safety and compliance. |
| Storage | 6-Bromo-1H-pyrrolo[3,2-b]pyridine should be stored in a tightly sealed container, protected from light and moisture, in a cool, dry, and well-ventilated area. Keep away from sources of ignition and incompatible substances such as strong oxidizing agents. Label the container clearly, and handle the compound in accordance with standard laboratory safety protocols. |
| Shelf Life | 6-bromo-1H-pyrrolo[3,2-b]pyridine should be stored in a cool, dry place; shelf life is typically 2-3 years. |
|
Purity 98%: 6-bromo-1H-pyrrolo[3,2-b]pyridine with a purity of 98% is used in pharmaceutical intermediate synthesis, where it ensures high reaction yield and product integrity. Melting Point 176°C: 6-bromo-1H-pyrrolo[3,2-b]pyridine with a melting point of 176°C is applied in organic electronic materials fabrication, where it delivers thermal stability during device processing. Molecular Weight 211.05 g/mol: 6-bromo-1H-pyrrolo[3,2-b]pyridine of molecular weight 211.05 g/mol is utilized in medicinal chemistry research, where it supports precise dosage calculations and reproducible biological activity. Reagent Grade: 6-bromo-1H-pyrrolo[3,2-b]pyridine of reagent grade is used in heterocyclic compound library construction, where it guarantees reliable reactivity and minimal side product formation. Stability Temperature 25°C: 6-bromo-1H-pyrrolo[3,2-b]pyridine with a stability temperature of 25°C is employed in laboratory storage for drug discovery workflows, where it maintains chemical integrity over extended periods. Particle Size <50 μm: 6-bromo-1H-pyrrolo[3,2-b]pyridine with a particle size less than 50 μm is used in high-throughput screening applications, where it provides rapid dissolution and uniform assay performance. Low Moisture Content <0.5%: 6-bromo-1H-pyrrolo[3,2-b]pyridine with low moisture content below 0.5% is utilized in API manufacturing, where it reduces hydrolytic degradation risk and extends shelf life. |
Competitive 6-bromo-1H-pyrrolo[3,2-b]pyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
6-Bromo-1H-pyrrolo[3,2-b]pyridine might not be the flashiest name around, but anyone who has spent real time with heterocyclic scaffolds in the lab recognizes this compound on sight. This molecule opens up a world of possibilities, especially for chemists working in fields from agrochemical discovery to pharmaceutical research. Its six-membered pyridine ring fused with a five-membered pyrrole means you’re not starting from scratch when building complexity on the bench.
The main feature here is the bromine atom sitting on the sixth position. That halogen makes a big difference, acting as a launchpad for a long list of further modifications. Cross-coupling reactions, such as Suzuki and Buchwald-Hartwig, get much easier with a reactive halide like this in place. I’ve seen it myself: a straightforward Suzuki-Miyaura coupling on this nucleus transforms a basic building block into something entirely new—sometimes for a new kinase inhibitor, sometimes for a materials science project. The reliability and versatility of this skeleton often mean fewer steps on the synthesis roadmap.
There’s no shortage of pyridine derivatives or pyrrole-containing intermediates out there, but the difference shows up once you try to scale or modify your process. Some analogs lack the reactivity that the bromine introduces. Others bring in unwanted side reactions or stability issues that clog up later steps. Many heterocycles are finicky in standard reaction conditions, sometimes because the wrong substituent sits on a critical position, sometimes because the ring doesn’t stand up to reagents.
This one stands up to a demanding synthesis schedule. We find ourselves going back to this scaffold when time or budget grows tight. Bromide at the 6-position doesn’t just increase reaction options—it narrows down purification challenges, especially if you’ve spent enough late nights with a silica column. Compared to iodo-analogs with higher reactivity but poorer availability, or chloro-analogs that trend toward stubbornness in certain cross-couplings, the bromo-derivative often delivers that right compromise. Its melting range and solubility don’t shine on a poster, but in the flask they enable both neat-handling and direct use without laborious pre-treatments.
In my own lab work, 6-bromo-1H-pyrrolo[3,2-b]pyridine proved essential for pushing into new target spaces, especially when the goal involved complex N-heterocyclic frameworks. You start with your core, plug into palladium-catalyzed couplings, and roll forward with variations: alkyls, aryls, even functional polymers if the project calls for it. Getting robust yields out of the coupling step means more time for creative problem-solving, less for triaging failed reactions.
This compound’s stability under typical benchtop humidity and moderate temperatures means I’ve lost less material to decomposition compared to other halogenated pyrollopyridines. Using this compound as a precursor, we finished analog libraries for SAR studies weeks ahead of schedule. One memorable project relied on its resilience against acidic or basic media, making it possible to explore reaction conditions which would knock out less tolerant building blocks.
The innovative part doesn’t end at synthesis. What researchers really want is a structure that opens doors—scaffolds where you add, swap, or decorate groups until you hit the desired property, whether it's solubility, binding affinity, or metabolic stability. Medicinal chemistry isn’t just about new bonds; it’s exploration under intense pressure. Every flexible intermediate that stands up under this stress brings relief, both mental and financial.
This molecule regularly appears in kinase inhibitor design, antiviral prototype work, and even in the photophysical studies for materials science adjuncts. Its basic skeleton, brominated just so, helps sidestep protection-deprotection cycles because its two rings share electronics without over-activating sensitivity or decreasing durability.
The pharmaceutical industry looks out for intermediates that can move quickly through verification steps, balancing purity, and compatibility with scale-up. In my experience, the crystalline nature of 6-bromo-1H-pyrrolo[3,2-b]pyridine lends itself to simple filtration at lab scale. The tendency for smooth product separation through normal-phase chromatography keeps things running efficiently once you reach mid-scale processes. Most impressively, the compound has managed to hold up through external quality audits—a minor miracle considering the hurdles of modern regulatory standards.
Small changes in a molecule's shape or connectivity change reactivity and selectivity. In this case, the arrangement of the nitrogen atoms in the pyrrole and pyridine fused system sets the stage for subsequent transformations. Reactions that fail with substitutes at the 2- or 3- positions open up with the 6-bromo group in place. The model matters because real-world chemistry doesn’t happen inside an idealized bottle—it deals with spatial hindrance, electron distribution, and the grind of impure reagents.
In a lot of settings—academic or industrial—chemists test libraries of similar structures in parallel to optimize activity. Only certain scaffolds take well to late-stage diversification. This one, with bromine as the starting point, lets researchers attach bulky groups or polar fragments without tearing apart the parent system. The model isn’t just a matter of tradition; it grows from repeated, reliable performance in tough settings.
Having a stable compound on your shelf is an asset most folks outside the lab forget. Buying a finicky or inconsistent batch means scrapping weeks of work if that single bottle lies about its purity or moisture sensitivity. With 6-bromo-1H-pyrrolo[3,2-b]pyridine, industry feedback has echoed what we see in-house: lots of lots pass purity and reproducibility testing right out of the package.
Anyone with experience in heterocyclic chemistry has their favorite toolkit molecules. If you’ve spent years building up SAR tables or working on radiotracers like I have, subtle differences between compounds start to matter a lot. For example, the chloro variants bring down reactivity in cross-couplings, sometimes improving selectivity but often lowering the achievable yield—something that helps at pilot scale but frustrates anyone who juggles small libraries of potential drug candidates.
The iodo versions practically sprint out of the gate in palladium chemistry, but they are usually harder to get. Sometimes the expense doesn’t justify the speed, especially in preliminary screening stages. Looking at methyl, nitro, or cyano derivatives, you trade away some synthetic flexibility and end up boxed into a smaller corner of chemistry’s playground. Bromine, by contrast, gives a sweet spot—active enough for common coupling twists, and robust enough for oddball reaction conditions.
There’s another important point: certain substituents increase risks of hazardous byproducts. Some halogenated intermediates break down into substances chemists would rather not deal with. In repeated proficiency testing, 6-bromo-1H-pyrrolo[3,2-b]pyridine doesn’t create nasty surprises under normal heating or scaling. This matters if you’re handing off an intermediate to another lab or moving toward regulated clinical candidate synthesis, where surprises chew up time and money.
No chemical intermediate comes without its headaches. With this compound, issues often rise around supply chain or pricing. Consistent sourcing can be tricky, especially if world events tie up raw material transport. Once or twice I’ve watched colleagues scramble for backup suppliers after an unexpected customs hold-up. The lesson here isn’t to rein in curiosity, but to diversify your ordering habits and keep small reserves for ongoing projects.
Purity is another big sticking point. At scale, even trace impurities from synthesis or workup steps create downstream screening issues. I’ve seen teams spend budget and morale trying to track down the cause of false positive results, only to realize a slightly impure batch threw off data. Trusted suppliers usually test for heavy-metal residues and UV-active impurities, but periodic in-house QC still makes a difference. It’s less about paranoia, and more about protecting months’ worth of hard work.
With proper storage—dry, out of sunlight, sealed tight—degradation remains a back-burner concern. At working lab scales, simple screw-cap amber vials keep reactivity consistent for months on end. Cross-lab sharing seems to bear this out: chemists report close to theoretical performance as long as handling stays clean, limiting excess exposure to moisture or acids.
Materials like 6-bromo-1H-pyrrolo[3,2-b]pyridine reflect real progress in chemical synthesis, not just for the big companies but for students, professors, and startup founders. The simplicity of using a well-behaved intermediate goes beyond technical convenience. It lets small teams attempt bold syntheses. If someone can cut five reaction cycles off a library assembly or circumvent harsh deprotection, the cost and risk of failure drop immediately. This broadens the pool of researchers who push the edges of medicinal chemistry, bioconjugation, or material development.
There’s a ripple effect: easy-to-use, stable, and reliable building blocks encourage more open and transparent reporting of synthetic strategy. Scientists waste less time troubleshooting and devote more effort to theory, analysis, or discovery. Their progress flows into peer-reviewed journals, patents, and—one hopes—life-saving medicines or environmentally friendly materials.
In outreach and education, using robust compounds lets students try real reactions without fear of complex workups or hazardous side products. They get a rigorous but doable introduction to practical chemistry, and move into research internships with useful hands-on experience. A university instructor I know relies on intermediates like this for advanced undergraduate labs, building confidence while sidestepping the headaches of ultra-sensitive materials.
To deal with supply uncertainty, more labs shift toward local or regional suppliers, sometimes collaborating directly with custom synthesis houses. Group ordering and stock-sharing, much like medicine caches in hospitals, buffer against shortages without tying up funds in overlarge inventories.
Reducing purification pain often hinges on in-house analytics. Integrating solid LC-MS or NMR screening right before a big coupling step means problems pop up early, without derailing a long project. Standard protocols for flash chromatography or recrystallization save time. Scientific journals and preprint servers, eager to support reproducibility, see more detailed reports when researchers know their starting materials behave predictably.
Analogs still matter—a single derivative rarely fits every pathway. By sharing success and troubleshooting stories more openly in conferences or digital forums, chemists identify which modifications work best for new targets. Bigger chemical suppliers have started to batch-produce not just this bromo intermediate, but a family of related rings tailored for common diversification strategies. Networking and collaboration expand solution options, especially across borders and disciplines.
Today’s chemistry world demands both performance and accountability. A molecule like 6-bromo-1H-pyrrolo[3,2-b]pyridine carves out its own niche by being tough, cooperative, and easy to handle—a rare feat in the crowded field of heterocyclic intermediates. Whether for drug discovery, agrochemical design, or the next innovation in functional materials, this compound shapes up to be more than just another reagent on the shelf. My own time with it left a clear lesson: every tool counts, and the best ones help clear the path toward real difference-making science.